- Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling
-
Ouh YT, Min KJ
- KMID: 2470876
- J Gynecol Oncol.
- 2020 Mar;31(2):e50.
- doi: 10.3802/jgo.2020.31.e50
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study
-
Ørtoft G, Høgdall C, Hansen ES, Dueholm M
- KMID: 2470872
- J Gynecol Oncol.
- 2020 Mar;31(2):e22.
- doi: 10.3802/jgo.2020.31.e22
OBJECTIVE: To evaluate survival and recurrence in stage II endometrial cancer in relation to uterine risk stratification. Outcome for stage II was compared before and after the introduction of lymph... -
- CITED
-
- Close
- SHARE
-
- Close
- LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
-
Kunitomi H, Kobayashi , Wu RC, Takeda T, Tominaga E, Banno K, Aoki D
- KMID: 2470864
- J Gynecol Oncol.
- 2020 Mar;31(2):e11.
- doi: 10.3802/jgo.2020.31.e11
OBJECTIVE: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The LAMC1 gene, encoding... -
- CITED
-
- Close
- SHARE
-
- Close
- Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy
-
Ushijima K
- KMID: 2458913
- J Gynecol Oncol.
- 2019 Nov;30(6):e117.
- doi: 10.3802/jgo.2019.30.e117
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
-
Mitsuhashi A, Habu Y, Kobayashi , Kawarai Y, Ishikawa H, Usui H, Shozu M
- KMID: 2458897
- J Gynecol Oncol.
- 2019 Nov;30(6):e90.
- doi: 10.3802/jgo.2019.30.e90
OBJECTIVE: The present study investigated long-term outcomes of medroxyprogesterone acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia (AEH) and endometrial cancer (EC), and post-treatment conception. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹â¸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
-
Liu DD, Li J, Li X, Xie L, Qin L, Peng F, Cheng MH
- KMID: 2458896
- J Gynecol Oncol.
- 2019 Nov;30(6):e89.
- doi: 10.3802/jgo.2019.30.e89
OBJECTIVE: To investigate the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG), measured by preoperative ¹â¸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹â¸F-FDG PET/CT), in risk stratification of... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
-
Kwon JS
- KMID: 2457160
- J Gynecol Oncol.
- 2019 Sep;30(5):e92.
- doi: 10.3802/jgo.2019.30.e92
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
-
Ørtoft G, Lausten-Thomsen L, Høgdall C, Hansen ES, Dueholm M
- KMID: 2457158
- J Gynecol Oncol.
- 2019 Sep;30(5):e84.
- doi: 10.3802/jgo.2019.30.e84
OBJECTIVE: To evaluate the effect of lymph-vascular space invasion (LVSI) on location of recurrences in Danish patients with endometrial cancer. METHODS: This national cohort study (2005–2012) included 4,380 radically operated patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
-
Reijnen C, Visser NC, Kasius JC, Boll D, Geomini PM, Ngo H, Van Hamont D, Pijlman BM, Vos MC, Bulten J, Snijders M, Massuger L, Pijnenborg JM
- KMID: 2457150
- J Gynecol Oncol.
- 2019 Sep;30(5):e70.
- doi: 10.3802/jgo.2019.30.e70
OBJECTIVES: The global obesity epidemic has great impact on the prevalence of low-grade endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125 (CA-125) might contribute to improved identification of... -
- CITED
-
- Close
- SHARE
-
- Close
- The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
-
Chen X
- KMID: 2450244
- J Gynecol Oncol.
- 2019 Jul;30(4):e79.
- doi: 10.3802/jgo.2019.30.e79
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study
-
Casadio P, Guasina F, Talamo MR, Paradisi R, Morra C, Magnarelli G, Seracchioli R
- KMID: 2450241
- J Gynecol Oncol.
- 2019 Jul;30(4):e62.
- doi: 10.3802/jgo.2019.30.e62
OBJECTIVE: To report hysteroscopic treatment combined with levonorgestrel-releasing intrauterine device (LNG-IUD) to treat women with early well differentiated endometrial cancer (EC) at high surgical risk. METHODS: Nine women diagnosed with stage... -
- CITED
-
- Close
- SHARE
-
- Close
- A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
-
Zhang Z, Huang H, Feng F, Wang J, Cheng N
- KMID: 2450240
- J Gynecol Oncol.
- 2019 Jul;30(4):e61.
- doi: 10.3802/jgo.2019.30.e61
OBJECTIVE: This study aims to evaluate the effects and pregnancy outcomes of gonadotropin-releasing hormone agonist (GnRH agonist) combined with aromatase inhibitor (AI) in preserving the fertility of obese women with... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
-
Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F
- KMID: 2450236
- J Gynecol Oncol.
- 2019 Jul;30(4):e57.
- doi: 10.3802/jgo.2019.30.e57
OBJECTIVE: To investigate the efficacy of levonorgestrel-releasing intra-uterine system (LNG-IUS) treatment in patients affected by atypical complex hyperplasia/endometrial cancer (ACH/EC) wishing to preserve their fertility and to present fertility outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
-
Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin , Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester , Lévêque , Lavoué V, Koskas M, Uzan C, Canlorbe G
- KMID: 2450232
- J Gynecol Oncol.
- 2019 Jul;30(4):e53.
- doi: 10.3802/jgo.2019.30.e53
OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
-
Cho HW, Ouh YT, Lee JK, Hong JH
- KMID: 2450230
- J Gynecol Oncol.
- 2019 Jul;30(4):e51.
- doi: 10.3802/jgo.2019.30.e51
OBJECTIVE: The aim of this study was to verify the effects of hormone therapy (HT) on recurrence in endometrial cancer (EC) survivors using the Korean Health Insurance Review and Assessment... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
-
Salama A, Arafa M, ElZahaf E, Shebl AM, Awad AA, Ashamallah SA, Hemida R, Gamal A, Foda AA, Zalata K, Abdel-Hady ESM
- KMID: 2449339
- J Pathol Transl Med.
- 2019 May;53(3):164-172.
- doi: 10.4132/jptm.2019.02.12
BACKGROUND: In order to improve the efficacy of endometrial carcinoma (EC) treatment, identifying prognostic factors for high risk patients is a high research priority. This study aimed to assess the... -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic single-site staging operation for early-stage endometrial cancer: initial experience at a single institution
-
Chung H, Jang TK, Nam SH, Kwon SH, Shin SJ, Cho CH
- KMID: 2445072
- Obstet Gynecol Sci.
- 2019 May;62(3):149-156.
- doi: 10.5468/ogs.2019.62.3.149
OBJECTIVE: The aims of this study were to introduce surgical guidelines, and to evaluate the feasibility and safety of a robotic single-site staging (RSSS) operation for early-stage endometrial cancer. METHODS: Patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Does the adoption of sentinel node mapping allow to design a new trial testing the value of retroperitoneal staging in endometrial cancer?
-
Bogani G, Raspagliesi F
- KMID: 2440519
- J Gynecol Oncol.
- 2019 May;30(3):e68.
- doi: 10.3802/jgo.2019.30.e68
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy in endometrial cancer: new scenarios on the horizon
-
Di Tucci C, Capone C, Galati G, Iacobelli , Schiavi MC, Di Donato , Muzii L, Panici PB
- KMID: 2440518
- J Gynecol Oncol.
- 2019 May;30(3):e46.
- doi: 10.3802/jgo.2019.30.e46
This extensive review summarizes clinical evidence on immunotherapy and targeted therapy currently available for endometrial cancer (EC) and reports the results of the clinical trials and ongoing studies. The research... -
- CITED
-
- Close
- SHARE
-
- Close
- A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
-
Onal C, Sari SY, Yildirim B, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F
- KMID: 2440512
- J Gynecol Oncol.
- 2019 May;30(3):e28.
- doi: 10.3802/jgo.2019.30.e28
OBJECTIVE: To analyze the outcomes of sequential or sandwich chemotherapy (ChT) and radiotherapy (RT) in patients with node-positive endometrial cancer (EC). METHODS: Data from 4 centers were collected retrospectively for 179... -
- CITED
-
- Close
- SHARE
-
- Close
